These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8789039)

  • 1. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up.
    Bek B; Boeckh M; Lepenies J; Bieniek B; Arasteh K; Heise W; Deppermann KM; Bornhöft G; Stöffler-Meilicke M; Schuller I; Höffken G
    J Clin Microbiol; 1996 Feb; 34(2):457-9. PubMed ID: 8789039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.
    St George K; Boyd MJ; Lipson SM; Ferguson D; Cartmell GF; Falk LH; Rinaldo CR; Landry ML
    J Clin Microbiol; 2000 Apr; 38(4):1430-3. PubMed ID: 10747120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of quantitative pp65 cytomegalovirus antigenemia assay for human immunodeficiency virus-positive patients.
    Ranger-Rogez S; Couty JP; Nicot T; Denis F; Rogez JP; Riche A; Weinbreck P
    J Clin Microbiol; 1996 Dec; 34(12):3255-6. PubMed ID: 8940491
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.
    Landry ML; Ferguson D; Stevens-Ayers T; de Jonge MW; Boeckh M
    J Clin Microbiol; 1996 May; 34(5):1337-9. PubMed ID: 8727936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
    Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
    Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.
    Veal N; Payan C; Fray D; Sarol L; Blanchet O; Kouyoumdjian S; Lunel F
    J Clin Microbiol; 1996 Dec; 34(12):3097-100. PubMed ID: 8940454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.
    Bush CE; Sluchak-Carlsen JA
    J Clin Microbiol; 1998 Nov; 36(11):3410-1. PubMed ID: 9774608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.
    Storch GA; Buller RS; Bailey TC; Ettinger NA; Langlois T; Gaudreault-Keener M; Welby PL
    J Clin Microbiol; 1994 Apr; 32(4):997-1003. PubMed ID: 8027357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia.
    Mazzulli T; Drew LW; Yen-Lieberman B; Jekic-McMullen D; Kohn DJ; Isada C; Moussa G; Chua R; Walmsley S
    J Clin Microbiol; 1999 Apr; 37(4):958-63. PubMed ID: 10074509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients.
    Hoshino Y; Nagata Y; Taguchi H; Masunaga A; Fujino Y; Mochizuki M; Nakamura T; Iwamoto A
    Microbiol Immunol; 1999; 43(10):959-65. PubMed ID: 10585142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
    Hebart H; Müller C; Löffler J; Jahn G; Einsele H
    Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus pp65 antigenaemia as an indicator of end-organ disease in AIDS.
    Fox EF; Smith NA; Rice P; Dunn H; Peters BS
    Int J STD AIDS; 1998 Sep; 9(9):545-7. PubMed ID: 9764940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.